<DOC>
	<DOCNO>NCT02663375</DOCNO>
	<brief_summary>Post-market registry ACURATE TA™ Transapical Aortic Bioprosthesis ACURATE TA™ Delivery System implantation patient present severe symptomatic aortic stenosis collect continue surveillance data pertain safety performance device .</brief_summary>
	<brief_title>ACURATE TA™ Valve Implantation Registry : SAVI 2</brief_title>
	<detailed_description>The SAVI2 registry single arm , prospective , multicenter , non-randomized open registry 1 year follow-up Symetis ACURATE TA™ . The ACURATE TA™ aortic bioprosthesis minimal invasive implantation via transapical access treat patient severe symptomatic aortic stenosis conventional aortic valve replacement ( AVR ) via open surgery consider associate high surgical risk . The primary objective registry evaluate safety performance implantation safety 30-Day Follow-up .</detailed_description>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<criteria>Patient severe aortic stenosis Native aortic annulus diameter ≥ 21mm ≤ 27mm Patient willing participate study provide sign ECapproved informed consent The subject treat physician agree subject return require postprocedure followup visit Patients exclude registry eligible transcatheter treatment severe aortic stenosis ACURATE TA™ Delivery System per Instructions For Use .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>TAVI</keyword>
	<keyword>Aortic Stenosis</keyword>
	<keyword>Transcatheter aortic valve replacement</keyword>
	<keyword>Transcatheter aortic valve implantation</keyword>
	<keyword>Transapical Access</keyword>
</DOC>